Published in Women's Health Weekly, May 30th, 2002
Because human erythropoietin has been identified in breast milk and its receptors have been detected in the mucosal layers of the newborn intestine, researchers at the University of Wisconsin in Madison believe it may play a role in newborn intestinal vascularization.
"Our study is the first to examine the effects of recombinant erythropoietin (rhEPO) on the endothelium of the neonatal gastrointestinal tract," R.A. Ashley and colleagues, University of Wisconsin, Madison...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.